Table 1.

Clinical Inputs: Weibull Survival Curve-Fitting Parameters

PD-L1 Expression	Regimen	Scale (λ)	Shape (γ)	Adjusted R 2
Overall survival
≥50%	Pembrolizumab	0.063985	0.796046	0.999902
	Chemotherapy	0.041061	1.089799	0.999146
≥20%	Pembrolizumab	0.065791	0.816173	0.999862
	Chemotherapy	0.041653	1.066223	0.999218
≥1%	Pembrolizumab	0.072141	0.8074439	0.999866
	Chemotherapy	0.04438	1.059809	0.999284
Progression-free survival
≥50%	Pembrolizumab	0.144153	0.769625	0.998946
	Chemotherapy	0.062074	1.232194	0.998621
≥20%	Pembrolizumab	0.156777	0.770046	0.998626
	Chemotherapy	0.059433	1.226069	0.999018
≥1%	Pembrolizumab	0.16432	0.79536	0.998187
	Chemotherapy	0.065666	1.197265	0.999148

PD-L1, programmed cell death ligand 1.